ResMed is redoubling efforts to increase resupply with plans to make Snap, a software platform that monitors orders, ...

One of the most common treatments for obstructive sleep apnea is continuous positive airway pressure (CPAP) applied by a ... but there are also bundles for ResMed AirSense 10 ($339), Fisher ...

Most health insurance plans cover CPAP machines, as well as related items such as masks and tubing if they are prescribed for treating sleep apnea. For CPAP machines to be covered by insurance, you ...

ResMed posted robust revenue and earnings growth but faces operational cost pressure due to rising expenses.

On Thursday, ResMed Inc (NYSE:RMD) reported first-quarter adjusted EPS of $2.20, up 34% year over year, beating the consensus ...

ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep ...

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections.Please watch the video at Investors.com - S&P 500 Giants Report Earnings. Will Megacap Results Sustain ...

A CPAP can be a life changer, but many people – maybe 50% or more – don’t use it even if their doctor recommends it. It’s prescribed to help people with obstructive sleep apnea ...

ResMed operates two reporting units, historically named Sleep and Respiratory Care and SaaS. In alignment with the 2030 ...

Med’s leadership position in sleep apnea has combines its digital health ecosystem and new hardware to pair with smart watches and wearables that creates an end-to-end solution for diagnosis of sleep ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...